MEI Pharma's total assets for Q1 2025 were $27.75M, a decrease of -32.93% from the previous quarter. MEIP total liabilities were $2.87M for the fiscal quarter, a -65.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.